266
Views
11
CrossRef citations to date
0
Altmetric
Review Article

Development of a focal segmental glomerulosclerosis after pregnancy complicated by preeclampsia: case report and review of literature

, , , , &
Pages 1566-1569 | Received 12 Apr 2015, Accepted 19 May 2015, Published online: 11 Jun 2015

References

  • Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75–84
  • Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorder of pregnancy: statement from the International Society for the study of hypertension in pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV
  • Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997;99:2152–64
  • Cornelis T, Odutayo A, Keunen J, et al. The kidney in normal pregnancy and preeclampsia. Semin Nephrol 2011;31:4–14
  • Lafayette RA, Druzin M, Sibley R, et al. Nature of glomerular dysfunction in preeclampsia. Kidney Int 1998;54:1240–9
  • Hennessy A, Markis A. Preeclamptic nephropathy. Nephrology 2011;16:134–43
  • Henao DE, Mathieson PW, Saleem MA, et al. A novel renal perspective of preeclampsia: a look from the podocyte. Nephrol Dial Transplant 2007;22:1477–90
  • Son GH, Kim JH, Hwang JH, et al. Urinary excretion of nephrin in patients with severe preeclampsia: urinary nephrin in preeclampsia. Hypertens Pregnancy 2011;30:408–13
  • Sugimoto H, Hamano Y, Charytan D, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003;278:12605–8
  • Garovic VD, Wagner SJ, Petrovic LM, et al. Glomerular expression of nephrin and synaptopodin, but not podocin is decreased in kidney section from women with preeclampsia. Nephrol Dial Transplant 2007;4:1136–43
  • Zhao S, Gu X, Groom LJ, Wang Y. Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1 and nitrotyrosine expressions in kidney tissue section from women with preeclampsia. Reprod Sci 2009;16:970–9
  • Garovic VD, Wagner SJ, Tuner ST, et al. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 2007;196:320e1–e7
  • Kriz W. The pathogenesis of classic focal segmental glomerulosclerosis – lesson from rat models. Nephrol Dial Transplant 2003;18:39–44
  • Bar J, Kaplan B, Wittenberg C, et al. Microalbuminuria after pregnancy complicated by preeclampsia. Naphrol Dial Transplant 1999;14:1129–32
  • Viske BE, Irgens LM, Leivestad T, et al. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008;359:800–9
  • Wang IK, Muo CH, Chang YC, et al. Association between hypertensive disorder during pregnancy and end-stage renal disease: a population based study. CMAJ 2013;185:207–13
  • Maharaj AS, Saint-Geniez M, Maldonado AE, D’Amore PA. Vascular endothelial growth factor localization in the adult. Am J Pathol 2006;168:639–48
  • Sugimoto H, Hamano Y, Charytan D, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003;78:12605–8
  • Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–58
  • Satchell SC, Tasman CH, Singh A, et al. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int 2006;69:1633–40
  • Collino F, Bussolati B, Gerbaudo E, et al. Pre-eclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 2008;294:F1185–94
  • Wharram BL, Goyal M, Wiggins J, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxins-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005;16:2941–52
  • Matsusaka T, Xin J, Niwa S, et al. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte specific injury. J Am Soc Nephrol 2005;16:1013–23
  • Asano T, Niimura F, Pastan I, et al. Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol 2005;16:2257–62
  • Ichikawa I, Ma J, Motojima M, Masusaka T. Podocyte damage damages podocytes: autonomous vicious cycle that driver local spread of glomerular sclerosis. Curr Opin Nephrol Hypertens 2005;14:205–10
  • Fukuda A, Wickman LT, Venkatereddy MP, et al. Angitensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int 2012;81:40–55
  • Schonenberg E, Ehrich JH, Haller H, Schiffer M. The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant 2010;11:1–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.